They conducted immune surveillance in PD-L1 overexpressed colon carcinoma cell line (CT-26) models by enhancing the function of CD8+ and CD4+ T cells by silencing PD-L1, which ultimately led to effective tumor inhibition and longer survival. Here, CD274 is linked to colon carcinoma.